Anticoagulants
Anticoagulants are medicines that slow the body's clotting process, so clots form less easily. MedlinePlus calls them one of two types of blood thinners, says blood thinners do not break up clots that already exist but can stop them from getting bigger, and calls bleeding the most common side effect. This is the class page: the direct oral anticoagulants and the heparins have class pages of their own.
Also called Anticoagulant
- Drug
- In this atlas
Overview
Technical summary
Class page. MeSH heading D000925, Anticoagulants, is an exact match, with the scope note agents that prevent blood clotting. Boxed warnings on two US drug labels are recorded as label statements, not findings about the class: the label of one oral factor Xa inhibitor warns that stopping any oral anticoagulant early increases the risk of thrombotic events, and the label of one injected low molecular weight heparin warns of epidural or spinal hematomas in people who are anticoagulated. The page records no trial result and no dose.
Trials at a glance
The figures count the 23 registry trials in this atlas that name this drug or a product that contains it. Trials that use another name for it are not counted.
- Trials
- 23
- Phase 3 or 4
- 22
- Recruiting
- 2
- Regulatory decisions
- 0
| Phase | Recruiting | Completed | Terminated | Unknown status | All statuses |
|---|---|---|---|---|---|
| Phase 2 | 0 | 1 | 0 | 0 | 1 |
| Phase 3 | 0 | 3 | 0 | 2 | 5 |
| Phase 4 | 2 | 6 | 1 | 8 | 17 |
| All phases | 2 | 10 | 1 | 10 | 23 |
Conditions these trials study
- Heart attack (myocardial infarction)
- ST-elevation heart attack (STEMI)
- Acute coronary syndrome
- Stroke
- Arrhythmia (heart rhythm problems)
- Atrial fibrillation (AF)
- Chronic kidney disease (CKD)
- Coronary artery disease
- Unstable angina
- Aortic stenosis
Sponsors with the most trials
Drugs in this class
5 drugs in this atlas are filed under Anticoagulants, with the registry trials and FDA regulatory decisions this atlas holds for each. With Anticoagulants itself, the class has 33 distinct trials and 46 distinct FDA decisions; a trial or decision that two of them share counts once there.
About this drug
- Level
- Class
- Mechanism
- Slow down the body's process of making clots (MedlinePlus).
Claims and evidence
No claims are published for this drug yet.
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 23
Record details
- Record id
cardio:anticoagulants- Content hash
bd724acfa588138d4c6185543202daad374d785241f46d1eff2045cf931e89fb